002038.SZ
Beijing SL Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.37
−10.03%Aug 25, 2026, 12:35 UTC
Shuanglu Pharmaceutical reported a net loss of 255 million yuan attributable to shareholders for the first half of 2026, turning from a profit of 121 million yuan in the same period of 2025.
Source:Jul 21, 2026, 09:42 UTC
Shuanglu Pharmaceutical's finance head Ji Li resigned and Wei Yanfeng was appointed as the new finance head.
Source: